Posted in Default

Dr Reddy’s Laboratories rating: Buy | Healthy financials should aid growth

Continuing its efforts to improve its product portfolio, DRRD entered several deals in FY22: 1) the sale of certain non-core brands in India, Russia and…

Continue Reading... Dr Reddy’s Laboratories rating: Buy | Healthy financials should aid growth